Immune globulin - Bio Products Laboratory

Drug Profile

Immune globulin - Bio Products Laboratory

Alternative Names: Gammaplex; Subgam; Subgam-VF

Latest Information Update: 10 Feb 2017

Price : $50

At a glance

  • Originator Bio Products Laboratory
  • Class Immunoglobulins; Immunoproteins; Serum globulins
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Immunodeficiency disorders
  • Registered Immune thrombocytopenic purpura
  • Phase III Idiopathic thrombocytopenic purpura

Most Recent Events

  • 07 Feb 2017 Registered for Immune thrombocytopenic purpura (In adults) in USA (IV)
  • 07 Feb 2017 Registered for Immunodeficiency disorders (In adults) in USA (IV)
  • 07 Feb 2017 Safety data from the phase III bioequivalence trial released by Bio Products Laboratory
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top